TSPO Imaging Probe for Brain Tumors
Part of Cancer clinical trials.
This trial tests a special imaging agent (called TSPO probe) that may help doctors see brain tumors (gliomas) more clearly. It’s for people who already have a brain lesion and are scheduled for surgery or biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You have a brain lesion seen on a CT or MRI scan.
- You plan to have surgery or a biopsy to find out if it is a glioma.
- Your kidneys, liver, and blood counts must be in a healthy range (checked by blood and urine tests).
- You should not be pregnant or breastfeeding, and must not have had chemotherapy in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special PET scan that looks at a protein called TSPO, which may be active in tumors. It may help doctors understand and monitor certain cancers better.
This trial tests a new radioactive dye (TSPO probe) that may show inflammation after a heart attack. You will have a PET-MR scan to see if the probe helps doctors better understand heart damage.
This study tests whether a special radioactive scan that targets PSMA can help identify a high-grade brain tumor in people who are about to have surgery. It may help doctors better target treatment by confirming the tumor’s PSMA features using a radiolabeled imaging approach.
This trial looks at brain inflammation in people with Parkinson’s using a special PET scan. The goal is to understand how brain immune activity may relate to Parkinson’s, and how the scan results change over time.
This trial studies whether a brain PET scan using a medicine called FMISO can help show how active certain brain tumors are. It mainly aims to see if the scan is practical and useful in planning care for people with suspected or known brain tumors.
This study looks for connections between detailed brain scans and tumor genetic features in people with glioblastoma. It may help researchers find better ways to understand your tumor and tailor future care.
Hear when a new Glioma (Any Grade) in the Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.